HIV-1 protease variants from 100-fold drug resistant clinical isolates: Expression, purification, and crystallization

Protein Expression and Purification

Volumn 28, Issue 1, 2003, Pages 165-172

  Vickrey, John F ^a   Logsdon, Bradley C ^a   Proteasa, Gheorghe ^a   Palmer, Sarah ^b   Winters, Mark A ^c   Merigan, Thomas C ^c   Kovari, Ladislau C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Codon bias; Crystallization; HIV protease; Multi drug resistance

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037361444     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00650-2     Document Type: Article

References (41)

1. D.D. Richman, HIV chemotherapy, Nature 410 (2001) 995-1001.
2. H.L. Robinson, New hope for an AIDS vaccine, Nature Rev. Immunol. 2 (2002) 239-250.
3. A. Wlodawer, A. Gustchina, Structural and biochemical studies of retroviral proteases, Biochim Biophys. Acta. 1477 (2000) 16-34.
4. A. Wlodawer, Rational approach to AIDS drug design through structural biology, Annu. Rev. Med. 53 (2002) 595-614.
5. Y. Takeuchi, T. Nagumo, H. Hoshino, Low fidelity of cell-free DNA synthesis by reverse transcriptase of human immunodeficiency virus, J. Virol. 62 (1988) 3900-3902.
6. J.D. Roberts, B.D. Preston, L.A. Johnston, A. Soni, L.A. Loeb, T.A. Kunkel, Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro, Mol. Cell. Biol. 9 (1989) 469-476.
7. J. Weber, F. Grosse, Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA, Nucleic Acids Res. 17 (1989) 1379-1393.
8. A. Wlodawer, J.W. Erickson, Structure-based inhibitors of HIV-1 protease, Annu. Rev. Biochem. 62 (1993) 543-585.
9. Z. Chen, Y. Li, E. Chen, D.L. Hall, P.L Darke, C. Culberson, J.A. Shafer, L.C. Kuo, Crystal structure at 1.9 Å resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases, J. Biol. Chem. 269 (1994) 26344-26348.
10. L. Hong, X.C. Zhang, J.A. Hartsuck, J. Tang, Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance, Protein Sci. 9 (2000) 1898-1904.
11. N.M. King, L. Melnick, M. Prabu-Jeyabalan, E.A. Nalivaika, S.S. Yang, Y. Gao, X. Nie, C. Zepp, D.L. Heefner, C.A. Schiffer, Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease, Protein Sci. 11 (2002) 418-429.
12. S. Palmer, R.W. Shafer, T.C. Merigan, Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development, AIDS 13 (1999) 661-667.
13. J.H. Miller, A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor Laboratory Press, Cold Sting Harbor, NY, 1992.
14. J.P. Huff, B.J. Grant, C.A. Penning, K.F. Sullivan, Optimization of routine transformation of Escherichia coli with plasmid DNA, Biotechniques 9 (1990) 570-572, see also, p. 574, pp. 576-577.
15. R. Kim, S.J. Sandler, S. Goldman, H. Yokota, A.J. Clark, S.H. Kim, Overexpression of archaeal proteins in Escherichia coli, Biotechnol. Lett. 20 (1998) 207-210.
16. T. Maniatis, E.R. Fritsch, I. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, Cold Spring Harbor, NY, 1982.
17. S.V. Gulnik, L.I. Suvorov, B. Liu, B. Yu, B. Anderson, H. Mitsuya, J.W. Erickson, Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure, Biochemistry 34 (1995) 9282-9287.
18. J.E Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.), Current Protocols in Science, Wiley, New York, 2001.
19. J.F. Vickrey, G. Herve, D.R. Evans, Pseudomonas aeruginosa Aspartate Transcarbamoylase, Characterization of its Catalytic and Regulatory Properties, J. Biol. Chem. 277 (2002) 24490-24498.
20. P.J. Ala, E.E. Huston, R.M. Klabe, D.D. McCabe, J.L. Duke, C.J. Rizzo, B.D. Korant, R.J. DeLoskey, P.Y. Lam, C.N. Hodge, C.H. Chang, Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors [published erratum appears in Biochemistry 1997 May 27;36(21):6556], Biochemistry 36 (1997) 1573-1580.
21. E.T. Baldwin, T.N. Bhat, S. Gulnik, B. Liu, I.A. Topoi, Y. Kiso, T. Mimoto, H. Mitsuya, J.W. Erickson, Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine, Structure 3 (1995) 581-590.
22. E.T. Baldwin, T.N. Bhat, B. Liu, N. Pattabiraman, J.W. Erickson, Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase, Nat. Struct. Biol. 2 (1995) 244-249.
23. P.L. Beaulieu, P.C. Anderson, D.R. Cameron, G. Croteau, V. Gorys, C. Grand-Maitre, D. Lamarre, F. Liard, W. Paris, L. Plamondon, F. Soucy, D. Thibeault, D. Wernic, C. Yoakim, S. Pav, L. Tong, 2′,6′-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors, J. Med. Chem. 43 (2000) 1094-1108.
24. L. Hong, A. Treharne, J.A. Hartsuck, S. Foundling, J. Tang, Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases, Biochemistry 35 (1996) 10627-10633.
25. H. Jhoti, O.M. Singh, M.P. Weir, R. Cooke, P. Murray-Rust, A. Wonacott, X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease, Biochemistry 33 (1994) 8417-8427.
26. G. Lange-Savage, H. Berchtold, A. Liesum, K.H. Budt, A. Peyman, J. Knolle, J. Sedlacek, M. Fabry, R. Hilgenfeld, Structure of HOE/BAY 793 complexed to human immunodeficiency virus (HIV-1) protease in two different crystal forms-structure/function relationship and influence of crystal packing [published erratum appears in Eur J Biochem 1997 Nov 1;249(3):912], Eur. J. Biochem. 248 (1997) 313-322.
27. J.L. Martin, J. Begun, A. Schindeler, W.A. Wickramasinghe, D. Alewood, P.F. Alewood, D.A. Bergman, R.I. Brinkworth, G. Abbenante, D.R. March, R.C. Reid, D.P. Fairlie, Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease, Biochemistry 38 (1999) 7978-7988.
28. A.M. Mulichak, J.O. Hui, A.G. Tomasselli, R.L. Heinrikson, K.A. Curry, C.S. Tomich, S. Thaisrivongs, T.K. Sawyer, K.D. Watenpaugh, The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors, J. Biol. Chem. 268 (1993) 13103-13109.
29. S. Munshi, Z. Chen, Y. Yan, Y. Li, D.B. Olsen, H.B. Schock, B.B. Galvin, B. Dorsey, L.C. Kuo, An alternate binding site for the P1-P3 group of a class of potent HIV-1 protease inhibitors as a result of concerted structural change in the 80s loop of the protease, Acta Crystallogr. D Biol. Crystallogr. 56 (Pt 4) (2000) 381-388.
30. K.H. Murthy, E.L. Winborne, M.D. Minnich, J.S. Culp, C. Debouck, The crystal structures at 2.2 Å resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations, J. Biol. Chem. 267 (1992) 22770-22778.
31. R.S. Randad, L. Lubkowska, A.M. Silva, D.M. Guerin, S.V. Gulnik, B. Yu, J.W. Erickson, Structure-based design of achiral, nonpeptidic hydroxybenzamide as a novel P2/P2′ replacement for the symmetry-based HIV protease inhibitors, Bioorg. Med. Chem. 4 (1996) 1471-1480.
32. R.B. Rose, C.S. Craik, N.L. Douglas, R.M. Stroud, Three-dimensional structures of HIV-1 and SIV protease product complexes, Biochemistry 35 (1996) 12933-12944.
33. H.I. Skulnick, P.D. Johnson, P.A. Aristoff, J.K Morris, K.D. Lovasz, W.J. Howe, K.D. Watenpaugh, M.N. Janakiraman, D.J. Anderson, R.J. Reischer, T.M. Schwartz, L.S. Banitt, P.K. Tomich, J.C. Lynn, M.M. Horng, K.T. Chong, R.R. Hinshaw, L.A. Dolak, E.P. Seest, F.J. Schwende, B.D. Rush, G.M. Howard, L.N. Toth, K.R. Wilkinson, K.R. Romines, et al., Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones, J. Med. Chem. 40 (1997) 1149-1164.
34. A.L. Swain, M.M. Miller, J. Green, D.H. Rich, J. Schneider, S.B. Kent, A. Wlodawer, X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor, Proc. Natl. Acad. Sci. USA 87 (1990) 8805-8809.
35. S. Thaisrivongs, D.L. Romero, R.A. Tommasi, M.N. Janakiraman, J.W. Strohbach, S.R. Turner, C. Biles, R.R. Morge, P.D. Johnson, P.A. Aristoff, P.K. Tomich, J.C. Lynn, M.M. Horng, K.T. Chong, R.R. Hinshaw, W.J. Howe, B.C. Finzel, K.D. Watenpaugh, Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors, J. Med. Chem. 39 (1996) 4630-4642.
36. M.D. Varney, K. Appelt, V. Kalish, M.R. Reddy, J. Tatlock, C.L. Palmer, W.H. Romines, B.W. Wu, L. Musick, Crystal-structure-based design and synthesis of novel C-terminal inhibitors of HIV protease, J. Med. Chem. 37 (1994) 2274-2284.
37. B.D. Preston, Reverse transcriptase fidelity and HIV-1 variation, Science 275 (1997) 228-229, discussion 230-221.
38. M.H. Bucher, A.G. Evdokimov, D.S. Waugh, Differential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein, Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 392-397.
39. A.M. Mildner, D.J. Rothrock, J.W. Leone, C.A. Bannow, J.M. Lull, I.M. Reardon, J.L. Sarcich, W.J. Howe, C.S. Tomich, C.W. Smith, et al., The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties, Biochemistry 33 (1994) 9405-9413.
40. J.R. Rose, R. Salto, C.S. Craik, Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions, J. Biol. Chem. 268 (1993) 11939-11945.
41. M. Prabu-Jeyabalan, E. Nalivaika, C.A. Schiffer, Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes, Structure (Camb) 10 (2002) 369-381.